Via The Medical News :
" Research just published that identifies new highly antibiotic-resistant bacteria reinforces the frequency with which similar strains of so-called “superbugs” are being discovered across Europe, according to the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
The study by Professor Timothy Walsh from Cardiff University and colleagues, published in The Lancet Infectious Diseases, reports the occurrence in several common bacteria of a resistance mechanism called New Delhi metallo-beta-lactamase (NDM-1) that makes those bacteria unresponsive to treatment with almost all antibiotics, including ones often used as a last resort, called carbapenems.
“These latest reports on the rapid spread of drug-resistant bacteria reinforce the nature and size of the problem that we face,” says Professor Giuseppe Cornaglia, President of the European Society of Clinical Microbiology and Infectious Diseases.
“Across Europe we have been monitoring and reporting on the emergence of similar carbapenem-resistant bacteria for the past 10 years, since their first appearance in Verona, Italy. Experiences from countries such as Italy, Greece and Israel have shown that if public health professionals do not have sufficient preparedness plans and resources allocated, infection caused by carbapenem-resistant bacteria poses a substantial threat to both patients and the healthcare system."
No comments:
Post a Comment